Literature DB >> 12487285

Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes.

Hiromitsu Jinno1, Tadashi Ikeda, Akira Matsui, Yuko Kitagawa, Masaki Kitajima, Hirofumi Fujii, Kayoko Nakamura, Atsushi Kubo.   

Abstract

Axillary lymph node dissection (ALND) in the treatment of breast cancer is essential for predicting the prognosis and regional control of the tumor. At the same time ALND is associated with pain, numbness and sometimes lymphedema. Sentinel lymph node biopsy (SLNB) is a potential alternative procedure to conventional ALND in clinically node-negative breast cancer. In this study, we prepared the technetium-99m-labeled tin colloids with different sizes and compared their efficacy in SLNB. From September 1998 to February 2002, 184 clinically node-negative breast cancer patients were enrolled in the study at Keio University Hospital. Sentinel lymph nodes (SLNs) were identified by both blue dye and radioisotope. We prepared small-sized technetium-99m-labeled tin colloid (particle size: 200-400 nm in diameter). Regular-sized technetium-99m-labeled tin colloid is 400-1000 nm in diameter. In 74 patients, a SLNB was performed using regular-sized tin colloid; small-sized tin colloid was used in 110 patients. Subsequently, all of the patients were immediately followed by ALND. All dissected lymph nodes were evaluated by routine histopathological examination. The clinicopathological characteristics of the two groups were comparable. The lymphoscintigram detected SLN more frequently in the small-sized colloid group than in the regular-sized colloid group (P < 0.01). Small-sized tin colloid was also superior to regular-sized tin colloid in the SLN identification rate (97.3% versus 86.5%; P = 0.01). The mean value for ex vivo counts of the hottest sentinel lymph nodes of the small-sized colloid group was significantly higher than the counts of the regular-sized colloid group (P < 0.01). There was no significant difference in the accuracy between the two groups. It was concluded that SLNB using the small-sized tin colloid was technically feasible and provided higher detection and identification rates than the regular-sized tin colloid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12487285     DOI: 10.1016/s0753-3322(02)00222-6

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  5 in total

1.  In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells.

Authors:  Li-Feng Qi; Zi-Rong Xu; Yan Li; Xia Jiang; Xin-Yan Han
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

2.  Sentinel lymph node radiolocalization with 99mTc filtered tin colloid in clinically node-negative squamous cell carcinomas of the oral cavity.

Authors:  Han-Sin Jeong; Chung-Hwan Baek; Young-Ik Son; Do-Yeon Cho; Man Ki Chung; Jin-Young Min; Young-Hyeh Ko; Byung-Tae Kim
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

3.  99mTc-phytate is better than 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer.

Authors:  Hiroyuki Takei; Kimito Suemasu; Masafumi Kurosumi; Jun Ninomiya; Yoshio Horii; Kenichi Inoue; Toshio Tabei
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  The Noninvasive Treatment for Sentinel Lymph Node Metastasis by Photodynamic Therapy Using Phospholipid Polymer as a Nanotransporter of Verteporfin.

Authors:  Kyosuke Shimada; Sachiko Matsuda; Hiromitsu Jinno; Noriaki Kameyama; Tomohiro Konno; Tsunenori Arai; Kazuhiko Ishihara; Yuko Kitagawa
Journal:  Biomed Res Int       Date:  2017-04-03       Impact factor: 3.411

5.  Optimal imaging time for Tc-99m phytate lymphoscintigraphy for sentinel lymph node mapping in patients with breast cancer.

Authors:  Ching-Chun Ho; Yu-Hung Chen; Shu-Hsin Liu; Hwa-Tsung Chen; Ming-Che Lee
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.